We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
107 result(s) found, displaying 31 to 40
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Fluid transfer set, general-purpose.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Intravenous fluid container, single use.
-
Prescription medicine decision summaryTGA decision: Xembify (normal immunoglobulin human) is approved to treat primary immunodeficiency diseases (PID).
-
Australian public assessment report (AusPar)VeraSeal (human fibrinogen and human thrombin) for the supportive treatment of hemostasis.
-
Prescription medicine registrationActive ingredients: human immunoglobulin G.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Immunohaematology calibrator/control IVDs.
-
Prescription medicine decision summaryTGA decision: VeraSeal (human fibrinogen/ human thrombin) is approved to treat hemostasis.
-
Prescription medicine registrationActive ingredients: human fibrinogen; human thrombin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Instrument/analyser IVDs.